Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
1
9%
Ph phase_4
2
18%
Ph not_applicable
4
36%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)
Other(3)

Detailed Status

Completed5
unknown3
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (14.3%)
Phase 42 (28.6%)
N/A4 (57.1%)

Trials by Status

completed545%
terminated19%
not_yet_recruiting218%
unknown327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11